Organon Pharma Indonesia Tbk. vs Sona Topas Tourism Industry Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sona Topas Tourism Industry Tbk. trades at Rp2,250 (market cap 1.49T, 8.7K 24h volume). The key difference: Sona Topas Tourism Industry Tbk. is far larger — about 14.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SONA | |
|---|---|---|
Market Cap | 104.4B | 1.49T |
Volume | — | 8.7K |
Lot | — | 87 |
Turnover | — | 19.49M |
Average Price | — | 2,240.57 |
Value | — | 19.49M |
Indicative Equilibrium Price | — | 2,250 |
Indicative Equilibrium Volume | — | 5 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Sona Topas Tourism Industry Tbk (the Company) was established based on notarial deed No.56 dated August 25, 1978 of Djonny Imam Soedjono for Edison Sianipar SH, under the name of PT Sona Topas Group. PT Sona Topas Tourism Industry Tbk has focused on providing tourism related services. The Company became a public listed company in July 1992 when it made an IPO and currently, all its 165,600,000 shares are traded on the JSX. The Company’s commercial operations started in 1980.
Read more on SONA →